from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3372/otsB2

LFCtreatmentdescriptionclass of inhibitor

-0.954

Amikacinug/mL Amikacintranslation

-0.437

Cap5-10ug/mL Capreomycintranslation

-0.381

Rox10-50 ug/mL Roxithromycintranslation

0.211

SM2-5 ug/mL Streptomycintranslation

-2.104

Tet5-10 ug/mL Tetracyclinetranslation

1.231

Rif0.2-5ug/mL Rifampicintranscription

0.807

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.268

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.668

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.729

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.393

Clofazimine10-13 ug/mL Clofaziminerespiration

0.448

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.102

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.764

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.448

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.057

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.171

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.893

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.095

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.887

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.763

KCN5-20 ug/mL Potassium cyaniderespiration

-0.422

NaN30.2-2 mM Sodium aziderespiration

-0.496

Nigericin50 uM Nigericinrespiration

-0.566

TRC10-150 ug/mL Triclosanrespiration

-1.225

TRZ10-25 ug/mL Thioridazinerespiration

-0.538

Valinomycin0.5-10 uM Valinomycinrespiration

-2.173

ZnSO42 mM ZnSO4respiration

0.252

menadione6-10 ug/mL Menadionerespiration

-0.533

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.392

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.259

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.019

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.308

NRP_1Non-replicating persistence stage 1dosRassociated

-0.065

Amp0.2mg/mL AmpicillincellWall

0.141

Cephalexin20-100 ug/mL CephalexincellWall

0.018

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.048

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.089

EMB10-20 ug/mL EthambutolcellWall

-0.533

Eta12-40 ug/mL EthionamidecellWall

0.089

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.928

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.424

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.561

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.056

BZA0.12 mg/mL BenzamidearomaticAmides

0.825

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.166

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.122

H2O24 mM hydrogen peroxideDNAdamaging

0.510

Levo10 ug/mL LevofloxacinDNAdamaging

0.633

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.377

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.599

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.704

UVUV-irradiationDNAdamaging

1.231

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.019

Antimycin12.5-50 ug/mL Antimycin A?

-0.127

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.032

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.379

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.623

PA8240.2-2 ug/mL PA-824?

-0.982

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.246

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.359

Verapamil50 uM Verapamil?

-0.035

mercaptoethanol2 mM 2-Mercaptoethanol?

0.538

methoxatin10-20 ug/mL Methoxatin?